EMBOTRIECIN

Dead / Abandoned — Abandoned — no statement of use filed (as of 10 Apr 2023)

What this means for you

This application is over — abandoned 10 Apr 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
90377673
Mark type
Stylized text
Filed
12 Dec 2020
Published for opposition
13 Jul 2021
Abandoned
10 Apr 2023
Attorney of record
Timothy K Kroninger

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention, treatment, and cure of cardiovascular disease; Pharmaceutical preparations for the treatment of hypertension and heart failure

Owner

Prosecution history

  • 10 Apr 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
  • 10 Apr 2023 — ABANDONMENT - NO USE STATEMENT FILED
  • 28 Sept 2022 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
  • 08 Sept 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 06 Sept 2022 — SOU EXTENSION 2 GRANTED
  • 06 Sept 2022 — SOU EXTENSION 2 FILED
  • 06 Sept 2022 — SOU TEAS EXTENSION RECEIVED
  • 03 Mar 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 28 Feb 2022 — SOU EXTENSION 1 GRANTED
  • 28 Feb 2022 — SOU EXTENSION 1 FILED
  • 28 Feb 2022 — SOU TEAS EXTENSION RECEIVED
  • 07 Sept 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 13 Jul 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 13 Jul 2021 — PUBLISHED FOR OPPOSITION
  • 23 Jun 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

View this trademark record on Marksy